Harfst & Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,165
Closed -$627K 148
2020
Q4
$627K Buy
6,165
+2,388
+63% +$224K 0.23% 76
2020
Q3
$317K Buy
3,777
+151
+4% +$11.8K 0.13% 97
2020
Q2
$235K Buy
3,626
+511
+16% +$33.7K 0.1% 100
2020
Q1
$202K Buy
3,115
+51
+2% +$4.02K 0.1% 97
2019
Q4
$241K Sell
3,064
-33
-1% -$2.57K 0.09% 90
2019
Q3
$246K Buy
3,097
+153
+5% +$12K 0.1% 89
2019
Q2
$246K Hold
2,944
0.1% 86
2019
Q1
$232K Buy
+2,944
New +$215K 0.1% 89
2018
Q4
Sell
-2,757
Closed -$220K 97
2018
Q3
$220K Buy
+2,757
New +$206K 0.09% 83
2017
Q3
Sell
-2,433
Closed -$134K 220
2017
Q2
$134K Buy
2,433
+503
+26% +$26.2K 0.05% 110
2017
Q1
$96K Buy
+1,930
New +$94.1K 0.04% 123

Other funds holding XYL

Harfst & Associates's XYL Position: Q1 2021 in Review

Harfst & Associates sold out of Xylem (XYL) in Q1 2021, closing a stake of 6,165 shares — an estimated $627K sold.

Harfst & Associates first reported a position in XYL in Q1 2017 and held it in 11 quarters. The position peaked at $627K in Q4 2020. 749 funds tracked by Wall St. Rank hold XYL as of Q1 2021.

  • Harfst & Associates reported no remaining Xylem position as of Q1 2021 after selling out during the quarter.
  • Harfst & Associates sold 6,165 Xylem shares in Q1 2021, an estimated $627K.
  • Harfst & Associates first reported a position in Xylem in Q1 2017 and held it in 11 quarters.
  • Harfst & Associates's Xylem position peaked at $627K in Q4 2020.
  • 749 funds tracked by Wall St. Rank held Xylem as of Q1 2021.

Based on Harfst & Associates's 13F filing for Q1 2021, filed 10 May 2021.